- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Sun Pharma's US arm faces lawsuit from ex-employees over closure of a Plants
Sun Pharma's wholly owned US subsidiary, Caraco Pharmaceutical Laboratories is facing a class action suit in US from its ex-employees over closure of its plants at in Detroit and Farmington Hills.According to a report, the Mumbai Based pharma giant's subsidiary Caraco did not undertake the right procedure before laying off workers at the plant in 2009. According to sources, there were...
According to a report, the Mumbai Based pharma giant's subsidiary Caraco did not undertake the right procedure before laying off workers at the plant in 2009. According to sources, there were 178 employees laid off without any prior notice of the plant being shut down. This, according to the US manufacturing norms, is a violation as law states that you need to notify the employees at least 60 days prior. Thus, the workers filed a law suit against the management, which has now been accepted by the US Court of Appeals.
In a statement given by the company, the company said the court's judgement does not have any material impact on its performance or operations.
Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country.She is a member of the Association of Healthcare Journalists. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751